Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?

J Infect Dis. 2004 May 1;189(9):1743. doi: 10.1086/383131.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies / immunology
  • Antibodies / therapeutic use*
  • Cohort Studies
  • Double-Blind Method
  • Humans
  • Lactams / therapeutic use
  • Mice
  • Pneumonia, Pneumococcal / complications
  • Pneumonia, Pneumococcal / drug therapy
  • Pneumonia, Pneumococcal / immunology
  • Pneumonia, Pneumococcal / mortality*
  • Retrospective Studies
  • Sepsis / drug therapy
  • Sepsis / immunology
  • Sepsis / mortality*
  • Survival Analysis
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Anti-Bacterial Agents
  • Antibodies
  • Lactams
  • Tumor Necrosis Factor-alpha